InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Krishnan Rajesh, Chief Technology Officer. Insider active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 5 disclosures have been published. History available since 3 January 2022. The latest transaction was disclosed on 3 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Krishnan Rajesh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
11,838 shares@ US$0.496136.0% of flowCommon StockSEC:0001209191-24-000974:0
10,897 shares@ US$0.3624.1% of flowCommon StockSEC:0001209191-23-041312:0
6,238 shares@ US$1.0239.9% of flowCommon StockSEC:0001209191-23-002035:0
43,125 shares0Common StockSEC:0001209191-22-043737:0
29,867 shares0Common StockSEC:0001209191-22-001976:0
5 of 5 declarations
About Krishnan Rajesh
Rajesh Krishnan is Chief Technology Officer at Oncternal Therapeutics, Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and products. His expertise is essential for innovation and the success of Oncternal Therapeutics.
